ZA976645B - Insulin derivatives with increased zinc binding. - Google Patents

Insulin derivatives with increased zinc binding.

Info

Publication number
ZA976645B
ZA976645B ZA9706645A ZA976645A ZA976645B ZA 976645 B ZA976645 B ZA 976645B ZA 9706645 A ZA9706645 A ZA 9706645A ZA 976645 A ZA976645 A ZA 976645A ZA 976645 B ZA976645 B ZA 976645B
Authority
ZA
South Africa
Prior art keywords
insulin derivatives
zinc binding
increased zinc
increased
binding
Prior art date
Application number
ZA9706645A
Other languages
English (en)
Inventor
Johann Ertl
Paul Habermann
Karl Geisen
Gerhard Seipke
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA976645B publication Critical patent/ZA976645B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9706645A 1996-07-26 1997-07-25 Insulin derivatives with increased zinc binding. ZA976645B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19630242 1996-07-26

Publications (1)

Publication Number Publication Date
ZA976645B true ZA976645B (en) 1998-01-26

Family

ID=7800962

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9706645A ZA976645B (en) 1996-07-26 1997-07-25 Insulin derivatives with increased zinc binding.

Country Status (25)

Country Link
US (1) US6221837B1 (cs)
EP (1) EP0821006B1 (cs)
JP (1) JP4046388B2 (cs)
KR (1) KR100547922B1 (cs)
CN (2) CN1158305C (cs)
AR (1) AR008269A1 (cs)
AT (1) ATE264871T1 (cs)
AU (1) AU725201B2 (cs)
BR (1) BR9704117B1 (cs)
CA (1) CA2207078C (cs)
CZ (1) CZ292274B6 (cs)
DE (1) DE59711533D1 (cs)
DK (1) DK0821006T3 (cs)
ES (1) ES2218622T3 (cs)
HK (1) HK1048125A1 (cs)
HU (1) HU224591B1 (cs)
IL (2) IL121381A (cs)
NO (1) NO317666B1 (cs)
NZ (1) NZ328421A (cs)
PL (1) PL188617B1 (cs)
PT (1) PT821006E (cs)
RU (1) RU2176646C2 (cs)
TR (1) TR199700685A3 (cs)
TW (1) TW474944B (cs)
ZA (1) ZA976645B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710167B1 (en) 1998-08-24 2004-03-23 Aventis Pharma Deutschland Gmbh Procedure for the chromatographic purification of insulins

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19825447A1 (de) * 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19947456A1 (de) * 1999-10-02 2001-04-05 Aventis Pharma Gmbh C-Peptid zur verbesserten Herstellung von Insulin und Insulinanaloga
US7238663B2 (en) * 2001-08-28 2007-07-03 Eli Lilly And Company Pre-mixes of GLP-1 and basal insulin
JP2005508360A (ja) * 2001-10-19 2005-03-31 イーライ・リリー・アンド・カンパニー Ｇｌｐ−１およびインスリンの二相混合物
KR100769183B1 (ko) * 2001-12-28 2007-10-23 엘지.필립스 엘시디 주식회사 면발광 램프
US20060217290A1 (en) * 2003-04-29 2006-09-28 Kohn Wayne D Insulin analogs having protracted time action
CA2531988C (en) * 2003-08-05 2016-06-28 Novo Nordisk A/S Novel insulin derivatives
CN103223160B (zh) 2004-07-19 2015-02-18 比奥孔有限公司 胰岛素-低聚物共轭物,制剂及其用途
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
CN101389650B (zh) 2005-12-28 2012-10-10 诺沃-诺迪斯克有限公司 包含酰化胰岛素和锌的组合物以及制备所述组合物的方法
JP5550338B2 (ja) 2006-07-31 2014-07-16 ノボ・ノルデイスク・エー／エス ペグ化持続型インスリン
JP5864834B2 (ja) * 2006-09-22 2016-02-17 ノボ・ノルデイスク・エー／エス プロテアーゼ耐性のインスリンアナログ
WO2008132224A2 (en) * 2007-04-30 2008-11-06 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
BRPI0812354A2 (pt) * 2007-06-01 2015-01-27 Novo Nordisk As Composição farmacêutica não-aquosa.
EP2167032B1 (en) * 2007-06-13 2019-08-07 Novo Nordisk A/S Pharmaceutical formulation comprising an insulin derivative
ES2664822T3 (es) * 2007-10-16 2018-04-23 Biocon Limited Una composición farmacéutica sólida administrable por vía oral y un proceso de la misma
US9260502B2 (en) * 2008-03-14 2016-02-16 Novo Nordisk A/S Protease-stabilized insulin analogues
WO2009115469A1 (en) 2008-03-18 2009-09-24 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
CA2738615A1 (en) * 2008-10-30 2010-05-06 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
RU2413531C2 (ru) * 2009-03-31 2011-03-10 Общество С Ограниченной Ответственностью "Концерн О3" Способ получения препарата с-пептида проинсулина для перорального применения
RU2013123515A (ru) 2010-10-27 2014-12-10 Ново Нордиск А/С Лечение сахарного диабета с помощью инъекций инсулина, вводимых с различными интервалами
ES2594303T3 (es) 2012-04-11 2016-12-19 Novo Nordisk A/S Formulaciones de insulina
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
RU2673185C2 (ru) 2013-10-07 2018-11-22 Ново Нордиск А/С Новое производное аналога инсулина
FR3013049B1 (fr) 2013-11-14 2015-11-13 You-Ping Chan Analogue de l'insuline glargine
HRP20211281T1 (hr) 2016-12-16 2021-11-12 Novo Nordisk A/S Pripravci koji sadrže inzulin
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
CN114096269B (zh) 2019-07-12 2024-06-11 诺和诺德股份有限公司 高浓度胰岛素制剂

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430260A (en) * 1979-02-27 1984-02-07 Lee Weng Y Penicillin-polyvinyl alcohol conjugate and process of preparation
FI78616C (fi) * 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
DE3326472A1 (de) 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3327709A1 (de) * 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DE3440988A1 (de) 1984-11-09 1986-07-10 Hoechst Ag, 6230 Frankfurt Verfahren zur spaltung von peptiden und proteinen an der methionyl-bindung
US4569794A (en) 1984-12-05 1986-02-11 Eli Lilly And Company Process for purifying proteins and compounds useful in such process
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DE3526995A1 (de) 1985-07-27 1987-02-05 Hoechst Ag Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung
DE3636903A1 (de) 1985-12-21 1987-07-02 Hoechst Ag Fusionsproteine mit eukaryotischem ballastanteil
DE3541856A1 (de) 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
DE3805150A1 (de) 1987-04-11 1988-10-20 Hoechst Ag Gentechnologisches verfahren zur herstellung von polypeptiden
DE4012818A1 (de) 1990-04-21 1991-10-24 Hoechst Ag Verfahren zur herstellung von fremdproteinen in streptomyceten
DE3726655A1 (de) 1987-08-11 1989-02-23 Hoechst Ag Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten
DE3739347A1 (de) 1987-11-20 1989-06-01 Hoechst Ag Verfahren zur selektiven spaltung von fusionsproteinen
EP0347781B1 (de) 1988-06-23 1994-02-16 Hoechst Aktiengesellschaft Mini-Proinsulin, seine Herstellung und Verwendung
DE3827533A1 (de) * 1988-08-13 1990-02-15 Hoechst Ag Pharmazeutische zubereitung zur behandlung des diabetes mellitus
DE3837825A1 (de) 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
NZ232375A (en) * 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
DE3921447A1 (de) * 1989-06-30 1991-01-17 Hoechst Ag Verfahren zur herstellung von n-alkyl-halogenanilinen
US5358857A (en) 1989-08-29 1994-10-25 The General Hospital Corp. Method of preparing fusion proteins
US5227293A (en) 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
GR1005153B (el) 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.
TW224471B (cs) * 1991-11-26 1994-06-01 Lilly Co Eli
ES2097426T3 (es) 1992-12-02 1997-04-01 Hoechst Ag Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
PL178466B1 (pl) * 1993-09-17 2000-05-31 Novo Nordisk As Pochodna insuliny i kompozycja farmaceutyczna do leczenia cukrzycy
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
EP0771208B1 (en) * 1994-08-12 2005-10-19 Immunomedics, Inc. Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710167B1 (en) 1998-08-24 2004-03-23 Aventis Pharma Deutschland Gmbh Procedure for the chromatographic purification of insulins

Also Published As

Publication number Publication date
AR008269A1 (es) 1999-12-29
NO973438L (no) 1998-01-27
PL321343A1 (en) 1998-02-02
CN1172811A (zh) 1998-02-11
RU2176646C2 (ru) 2001-12-10
JPH1072496A (ja) 1998-03-17
ATE264871T1 (de) 2004-05-15
TW474944B (en) 2002-02-01
HK1048125A1 (zh) 2003-03-21
HU224591B1 (hu) 2005-11-28
IL121381A0 (en) 1998-01-04
HU9701299D0 (en) 1997-09-29
IL121381A (en) 2004-09-27
ES2218622T3 (es) 2004-11-16
TR199700685A2 (xx) 1998-02-21
CZ292274B6 (cs) 2003-08-13
EP0821006A2 (de) 1998-01-28
EP0821006B1 (de) 2004-04-21
AU3017197A (en) 1998-02-05
HUP9701299A3 (en) 2001-04-28
PT821006E (pt) 2004-09-30
DK0821006T3 (da) 2004-08-16
CN1362417A (zh) 2002-08-07
CN1158305C (zh) 2004-07-21
MX9705667A (es) 1998-07-31
NZ328421A (en) 1998-12-23
CA2207078A1 (en) 1998-01-26
NO973438D0 (no) 1997-07-25
KR980009281A (ko) 1998-04-30
BR9704117B1 (pt) 2009-08-11
TR199700685A3 (tr) 1998-02-21
IL121382A0 (en) 1998-01-04
DE59711533D1 (de) 2004-05-27
PL188617B1 (pl) 2005-03-31
CZ237097A3 (cs) 1998-02-18
NO317666B1 (no) 2004-11-29
JP4046388B2 (ja) 2008-02-13
BR9704117A (pt) 1998-12-29
KR100547922B1 (ko) 2006-06-22
EP0821006A3 (de) 2001-11-28
HUP9701299A1 (hu) 1998-11-30
US6221837B1 (en) 2001-04-24
CA2207078C (en) 2008-01-29
AU725201B2 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
ZA976645B (en) Insulin derivatives with increased zinc binding.
HUP9801368A3 (en) New insulin derivatives with rapid action
ZA978579B (en) Herbicidal composition.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA979199B (en) Aminothiophenecarboxamides.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA978256B (en) Electrolyte.
ZA977206B (en) Arylalkanoylpyridazines.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
AU2556897A (en) Diabetic supplement bar
ZA973629B (en) Pesticidal composition.
ZA200006835B (en) Novel insulin analogs with enhanced zinc binding.
ZA971258B (en) Microbicides.
ZA974538B (en) Novel pyrrole derivatives.
GB2316686B (en) Sliding member.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA979725B (en) Benzoaxozole derivative.
ZA971638B (en) Microbicidal composition.
ZA975906B (en) Syringes.
ZA977791B (en) GLP-1 derivatives.
ZA976022B (en) Cycloalkano-pyridines.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
ZA971466B (en) Endothelin-receptor-antagonists.